SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses

被引:109
作者
Vibholm, Line K. [1 ]
Nielsen, S. F. [1 ]
Pahus, Marie H. [2 ]
Frattari, Giacomo S. [1 ]
Olesen, Rikke [1 ]
Andersen, Rebecca [1 ]
Monrad, Ida [1 ]
Andersen, Anna H. F. [2 ]
Thomsen, Michelle M. [2 ]
Konrad, Christina V. [2 ]
Andersen, Sidsel D. [2 ]
Hojen, Jesper F. [1 ]
Gunst, Jesper D. [1 ,2 ]
ostergaard, Lars [1 ,2 ]
Sogaard, Ole S. [1 ,2 ]
Schleimann, Mariane H. [1 ]
Tolstrup, Martin [1 ,2 ]
机构
[1] Aarhus Univ Hosp, Dept Infect Dis, Aarhus, Denmark
[2] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
关键词
SARS-CoV-2; Persistent PCR positive; Immunology; Antibodies; CD8 T cell responses; Transmission; Contact tracing; CORONAVIRUS;
D O I
10.1016/j.ebiom.2021.103230
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Upon SARS-CoV-2 infection, most individuals develop neutralizing antibodies and T-cell immunity. However, some individuals reportedly remain SARS-CoV-2 PCR positive by pharyngeal swabs weeks after recovery. Whether viral RNA in these persistent carriers is contagious and stimulates SARS-CoV-2-specific immune responses is unknown. Methods: This cohort study was conducted between April 3rd-July 9th 2020, recruiting COVID-19 recovered individuals that were symptom-free for at least 14 days. We collected serum for SARS-CoV-2-specific total Ig, IgA and IgM detection by ELISA, pharyngeal swabs (two time points) for ddPCR and PBMCs for anti-SARSCoV-2 CD8 T-cell dextramer analyses. Findings: We enrolled 203 post-symptomatic participants with a previous RT-PCR-verified SARS-CoV-2 infection. At time point 1, a median of 23 days (range 15-44) after recovery, 26 individuals (12.8%) were PCR positive. At time point 2, 90 days (median, range 85-105) after recovery, 5 (5.3%) were positive. There was no difference in SARS-CoV-2 antibody levels between the PCR negative and positive group. The persistent PCR positive group however, had SARS-CoV-2-specific CD8 T-cell responses of significantly increased breadth and magnitude. Assisted contact tracing among persistent PCR positive individuals revealed zero new COVID-19 diagnoses among 757 close contacts. Interpretation: Persistent pharyngeal SARS-CoV-2 PCR positivity in post-symptomatic individuals is associated with elevated cellular immune responses and thus, the viral RNA may represent replicating virus. However, transmission to close contacts was not observed indicating that persistent PCR positive individuals are not contagious at the post-symptomatic stage of the infection. (C) 2021 The Authors. Published by Elsevier B.V.
引用
收藏
页数:8
相关论文
共 43 条
[1]   Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting [J].
Abu-Raddad, Laith J. ;
Chemaitelly, Hiam ;
Malek, Joel A. ;
Ahmed, Ayeda A. ;
Mohamoud, Yasmin A. ;
Younuskunju, Shameem ;
Ayoub, Houssein H. ;
Al Kanaani, Zaina ;
Al Khal, Abdullatif ;
Al Kuwari, Einas ;
Butt, Adeel A. ;
Coyle, Peter ;
Jeremijenko, Andrew ;
Kaleeckal, Anvar Hassan ;
Latif, Ali Nizar ;
Shaik, Riyazuddin Mohammad ;
Rahim, Hanan F. Abdul ;
Yassine, Hadi M. ;
Al Kuwari, Mohamed G. ;
Al Romaihi, Hamad Eid ;
Al-Thani, Mohamed H. ;
Bertollini, Roberto .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (07) :E1830-E1840
[2]   Coronavirus outbreak in Nigeria: Burden and socio-medical response during the first 100 days [J].
Amzat, Jimoh ;
Aminu, Kafayat ;
Kolo, Victor, I ;
Akinyele, Ayodele A. ;
Ogundairo, Janet A. ;
Danjibo, Maryann C. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 98 :218-224
[3]   SARS-CoV-2 shedding and infectivity [J].
Atkinson, Barry ;
Petersen, Eskild .
LANCET, 2020, 395 (10233) :1339-1340
[4]  
Avanzato VA, 2020, CELL
[5]   Evaluation of the EUROIMMUN Anti-SARS-CoV-2 ELISA Assay for detection of IgA and IgG antibodies [J].
Beavis, Kathleen G. ;
Matushek, Scott M. ;
Abeleda, Ana Precy F. ;
Bethel, Cindy ;
Hunt, Carlissa ;
Gillen, Stephanie ;
Moran, Angelica ;
Tesic, Vera .
JOURNAL OF CLINICAL VIROLOGY, 2020, 129
[6]  
Beklevicc AC, 2020, AM J INFECT CONTROL, P1
[7]   Comparison of different serological assays for SARS-CoV-2 in real life [J].
Brochot, Etienne ;
Demey, Baptiste ;
Handala, Lynda ;
Francois, Catherine ;
Duverlie, Gilles ;
Castelain, Sandrine .
JOURNAL OF CLINICAL VIROLOGY, 2020, 130
[8]   Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples [J].
Bullard, Jared ;
Dust, Kerry ;
Funk, Duane ;
Strong, James E. ;
Alexander, David ;
Garnett, Lauren ;
Boodman, Carl ;
Bello, Alexander ;
Hedley, Adam ;
Schiffman, Zachary ;
Doan, Kaylie ;
Bastien, Nathalie ;
Li, Yan ;
Van Caeseele, Paul G. ;
Poliquin, Guillaume .
CLINICAL INFECTIOUS DISEASES, 2020, 71 (10) :2663-2666
[9]   Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers A Randomized Controlled Trial [J].
Bundgaard, Henning ;
Bundgaard, Johan Skov ;
Raaschou-Pedersen, Daniel Emil Tadeusz ;
von Buchwald, Christian ;
Todsen, Tobias ;
Norsk, Jakob Boesgaard ;
Pries-Heje, Mia M. ;
Vissing, Christoffer Rasmus ;
Nielsen, Pernille B. ;
Winslow, Ulrik C. ;
Fogh, Kamille ;
Hasselbalch, Rasmus ;
Kristensen, Jonas H. ;
Ringgaard, Anna ;
Andersen, Mikkel Porsborg ;
Goecke, Nicole Bakkegard ;
Trebbien, Ramona ;
Skovgaard, Kerstin ;
Benfield, Thomas ;
Ullum, Henrik ;
Torp-Pedersen, Christian ;
Iversen, Kasper .
ANNALS OF INTERNAL MEDICINE, 2021, 174 (03) :335-+
[10]   Active Monitoring of Persons Exposed to Patients with Confirmed COVID-19-United States, January-February 2020 [J].
Burke, Rachel M. ;
Midgley, Claire M. ;
Dratch, Alissa ;
Fenstersheib, Marty ;
Haupt, Thomas E. ;
Holshue, Michelle ;
Ghinai, Isaac ;
Jarashow, M. Claire ;
Lo, Jennifer ;
McPherson, Tristan D. ;
Rudman, Sara ;
Scott, Sarah ;
Hall, Aron J. ;
Fry, Alicia M. ;
Rolfes, Melissa A. .
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (09) :245-246